BrainsWay In the media

Publication Title Date
Psychiatry Advisor TMS Device Cleared to Treat Obsessive Compulsive Disorder 9/19
Newsweek What is TMS? The Most Effective ADHD Treatment May Also be the Most Controversial 9/5
Open Minds FDA Approves Use Of BrainsWay Transcranial Magnetic Stimulation For Treatment Of Obsessive Compulsive Disorder 9/4
DailyMail.com FDA approves magnetic brain-zapping helmet to treat OCD sufferers who don’t respond to therapy ordrugs 9/3
Medical Device Network FDA approval of Brainsway device opens a new route for OCD treatment 8/30
NeuroNews US FDA clears first magnetic, non-invasive device treatment for OCD 8/29
IEEE Spectrum BrainsWay’s Brain Stimulation Device Receives FDA Approval to Treat Obsessive-Compulsive Disorder 8/24
Pharmacy Times August 24 Pharmacy Week in Review: Contact Lens Hygiene, New Treatment for OCD 8/24
Becker’s Hospital Review A steroid to treat eye pain, a nontraditional OCD treatment & more: 4 latest FDA approvals 8/24
Psychiatry Advisor Deep Transcranial Magnetic Stimulation Combined With SSRIs Possibly Effective for Treatment-Resistant Depression 8/24
Mass Device BrainsWay wins ‘historic milestone’ clearance to treat OCD 8/22
MedPage Today 3-Minute TMS for Depression OK’d; Top Psych Hospitals Ranked; Rapid Brain Aging 8/22
Physiatry Advisor FDA Permits Marketing of Brain Stimulation Device for OCD 8/21
Vantage Transcranial magnetic stimulators attract attention 8/21
Pharmabiz.com BrainsWay’s Deep TMS system receives US FDA approval to treat obsessive-compulsive disorder in adults 8/21
Clinical Innovation and Technology FDA approves noninvasive device for treating OCD 8/20
Verdict Medical Devices Brainsway Deep TMS device secures FDA clearance for OCD 8/20
Medical Device and Diagnostic Industry BrainsWay’s New Indication Is Aimed at OCD Patients 8/20
Contemporary Clinic FDA Permits Marketing of Transcranial Magnetic Stimulation Device for Treatment of OCD 8/20
epgonline FDA approves BrainsWay Deep TMS system to treat Obsessive Compulsive Disorder.- Brainsway Ltd. 8/20
Medgadget Brainsway Transcranial Stimulation Cleared in U.S. for Obsessive Compulsive Disorder 8/20
FierceBiotech FDA clears first magnetic, noninvasive device treatment for OCD 8/20
MedTech Dive Noninvasive magnetic stimulation for OCD wins FDA nod 8/20
Health Data FDA approves device to treat obsessive-compulsive disorder 8/20
Compelo FDA approves Brainsway deep TMS system to treat OCD 8/20
CTECH FDA Approves Brainsway’s Magnetic Stimulation Headset for OCD Treatment 8/19
The Times of Israel Israeli OCD treatment gets FDA green light for US marketing 8/19
The Jerusalem Post FDA OKS BRAINSWAY NON-INVASIVE DEVICE TO TREAT OCD IN ADULTS 8/19
JewishPress.com FDA Approves Marketing for Israeli-Developed OCD Treatment 8/19
Globes BrainsWay wins FDA approval for brain stimulation system 8/19
Neurology Live Brainsway Deep Transcranial Magnetic Stimulation System for OCD Approved by FDA 8/17
MPR TMS Device Cleared to Treat Obsessive Compulsive Disorder 8/17
Pysch Congress Network FDA Clears Brainsway TMS as a Treatment for OCD 8/17
MedPage Today Magnetic Stimulation OK’d for OCD 8/17
Medscape FDA Clears Brain Stimulation Device for OCD 8/17
Mass Device Brainsway wins FDA nod for OCD-treating TMS system 8/17
BuzzFeed News The FDA Says This Brain-Stimulating Device May Help People With Obsessive-Compulsive Disorder 8/17
Medtech Insight OCD Indication Approved For Brainsway TMS Device 8/17
Psychiatric Annals FDA permits marketing of brain stimulation system for OCD 8/17
MD Mag Transcranial Magnetic Stimulation Device Approved for OCD Patient Marketing 8/17
Health Daily FDA Approves Brain Stimulation Device for OCD 8/17
FDA Press Release FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder 8/17